
Dr. Paul G Kluetz MD
Oncologist | Medical Oncology
22 S Greene St Baltimore MD, 21201About
Dr. Paul Kluetz is an oncologist practicing in Baltimore, MD. Dr. Kluetz specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Kluetz manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
University of Pittsburgh School of Medicine 2003
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Acute pulmonary embolism: imaging in the emergency department.
- Abiraterone acetate in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer: U.S. Food and Drug Administration drug approval summary.
- Radium Ra 223 dichloride injection: U.S. Food and Drug Administration drug approval summary.
- Pain palliation measurement in cancer clinical trials: the US Food and Drug Administration perspective.
- Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
- Patient-Reported Outcomes in Cancer Drug Development and US Regulatory Review: Perspectives From Industry, the Food and Drug Administration, and the Patient.
- FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer.
- Expansion Cohorts in First-in-Human Solid Tumor Oncology Trials.
- Looking to the future in an unprecedented time for cancer drug development.
- Neoadjuvant breast cancer therapy and drug development.
- FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer.
- Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.
Dr. Paul G Kluetz MD's Practice location
Paul Kluetz
3800 Reservoir Rd Nw Div Of Hospital Medi -Washington, DC 20007Get Direction
Dr. Paul G Kluetz MD's reviews
Write ReviewRecommended Articles
- What is Eye Melanoma?
What is eye melanoma?Eye melanoma is also known as ocular melanoma. It is a type of cancer that develops in the eye, from the melanin-producing cells.Melanoma is a type of malignant cancer that develops in the melanin-producing cells all over the human body. Melanin-producing cells are known for the...
- Sandra Lee, Breast Cancer Survivor, Wants You to be Neurotic About Your Health
October is referred to in the United States as National Breast Cancer Awareness Month. In honor of the annual campaign dedicated to raising awareness of the disease, Sandra Lee’s documentary short - “RX Early Detection: A Cancer Journey with Sandra Lee” - is filled with wry humor, tears, and...
- Chlamydia Doubled Ovarian Cancer Risk, Study Shows
Chlamydia trachomatis, commonly known as chlamydia, is a type of sexually transmitted infection (STI). In the United States, approximately 1.5 million cases of chlamydia are reported on an annual basis, making it the most commonly reported type of bacterial infection – according to the Centers for...
- New Advancement to Reduce Rate of Breast Cancer Spreading
One of the most difficult aspects of treating cancer is fighting against the speed at which the cancer spreads throughout the body. As cells grow and multiply, they begin to affect larger systems in the body, and can metastasize to different systems entirely. Once a cancer has spread from the...
- Report Finds Primary Care Programs for Cancer Survivors Are Lacking
‘Cancer survivor’ is a term that is commonly used in medical literature, where survivorship begins from diagnosis and initial treatment, to cure, cancer-free survival, and long-term follow-up care. Cancer survivors are becoming a fast growing population in the United States. According to the...
- Does Breast Cancer Occur More Often in Certain Areas of the US
Breast cancer is the second most common cancer in the United States, after skin cancers. Currently, it affects more than 1 in 10 women worldwide. The two most common risk factors of breast cancer are being female and becoming older. If you are a woman and you have a relative (mother, sister, or...
Nearby Providers
- Dr. Johann Brandes MD, PHD1650 Orleans Street Baltimore MD 21231
- Dr. Kit Lu M.D.4940 Eastern Ave Baltimore MD 21224
- Dr. Julie Brahmer M.D.401 North Broadway Baltimore Maryland 21231
- Dr. Evan Jacob Lipson MD1650 Orleans St Baltimore MD 21287
- Dr. Ivan Marques Borrello M.D.1650 ORLEANS ST BALTIMORE MD 21263
- Dr. Christian Frederick Meyer M.D., PH. D.1650 Orleans St Baltimore MD 21287
Nearest Hospitals
BON SECOURS HOSPITALl
2000 W BALTIMORE STREET BALTIMORE MD 21223SIBLEY MEMORIAL HOSPITALl
5255 LOUGHBORO RD NW WASHINGTON DC 20016HALQUIST MEMORIAL INPATIENT CENTERl
4715 NORTH 15 STREET ARLINGTON VA 22205